Pharmaceutical Technology

FEBRUARY 16, 2023

The University of Texas MD Anderson Cancer Center has entered a strategic collaboration with biotech company Xilis for advancing new technology and expediting new cancer therapy development. Under the deal, MD Anderson and Xilis aim to advance the development of drug and discovery projects using the MOS technology.

Pharmaceutical 96

Pharmaceutical Patients Medicine Leads 96

Medico Reach

DECEMBER 15, 2022

These are software applications that analyze the collected information from a range of sources, including but not limited to clinical research, operational activity, patient care programs and financial reports. Flexible deployment into existing applications. Payers (Patients, Registered members of digital health platforms, etc.).

Healthcare 98

Healthcare Healthcare Marketing Customer Relationship Management 98

Pharmaceutical Technology

MAY 24, 2023

ModeX Therapeutics will gain access to the fully human Harbour Mice platforms of Nona Bioscience for integration into its MSTAR platform to expedite the monoclonal antibodies’ discovery. This is expected to significantly shorten the preclinical antibody therapeutics development process.

59

59

Legacy MEDSearch

AUGUST 8, 2022

MicroPort Navibot has received 510(K) clearance from the Food and Drug Administration (FDA) in the United States for the SkyWalker System, the company’s first robot-assisted platform for orthopedic applications. Press Release by: MicroPort Orthopedics. Contact us to discuss partnering with Legacy MedSearch on your position.

Food and Drug Administration 98

Food and Drug Administration Recruitment Medical Food 98

European Pharmaceutical Review

JULY 27, 2023

This study offers a potential for a wide range of applications. Further development to the method is needed to suit specific use cases. If the solid-state storage method is successful, other potential applications include oral tablet biologics, which could replace injection for medications such as insulin and Humira.

Transportation 94

Transportation Medical Pharmaceutical 94

pharmaphorum

DECEMBER 9, 2022

The new graduates – selected out of 75 applicants in a hotly contested application process – are working on a diverse array of digital health platforms including remote patient monitoring techniques, biomarkers, drug discovery and analytics tools, data annotation platforms, therapeutic-area data models, and novel RWE datasets.

Patients 52

Patients Engineering Prospecting Pharma 52

European Pharmaceutical Review

FEBRUARY 13, 2023

Tokyo researchers have developed a new analytical platform based on liquid chromatography, mass spectrometry and software analysis that quantifies the structure of messenger RNA (mRNA)-based medicines. The team’s platform combines two important innovations. Currently no method that can quantify the state of all three in one go.

Medicine 104

Medicine Pharmaceutical Manufacturing 104

Pharmaceutical Technology

FEBRUARY 15, 2023

Gene therapy delivery using viral vectors is a key innovation area in immuno-oncology Viruses such as retrovirus, lentiviruses, alphaviruses, adenovirus, adeno-associated virus (AAV), and herpes simplex virus, have been modified in the laboratory for use in gene therapy applications.

Leads 98

Leads Pharmaceutical Medicine 98

Pharmaceutical Technology

MAY 23, 2023

Novartis will receive an exclusive licence for intellectual property related to the gene therapy platform of Avrobio for use in cystinosis and for other assets. Avrobio will retain complete rights to its HSC gene therapies portfolio developed to treat Pompe disease, Gaucher disease type 1 and type 3, and Hunter syndrome.

Food and Drug Administration 103

Food and Drug Administration Food Leads Pharmaceutical 103

Medgadget

MAY 30, 2023

Researchers at MIT have developed smart sutures with a hydrogel coating that contains sensing and drug delivery components, and could even be used to implant therapeutic cells. Just last February, Medgadget reported on sutures that could kill bacteria and show up in CT scans , developed by a team at RMIT University in Australia.

Medicine 85

Medicine Patients 85

European Pharmaceutical Review

JULY 17, 2023

A new three-year research programme led by researchers at Massachusetts Institute of Technology ( MIT ) is aiming to design the world’s first fully integrated, continuous mRNA manufacturing platform. If we can drive the cost and time of development down, we’ll enable all sorts of new applications.”

Manufacturing 96

Manufacturing Food and Drug Administration Engineering Biopharma 96

PM360

JANUARY 5, 2024

The Omega collaboration will leverage its proprietary platform technology to develop an epigenomic controller designed to enhance metabolic activity as a part of a potential new treatment approach for obesity management. This is an important moment in our partnership with Flagship Pioneering.

Medicine 52

Medicine Management Patients Sales 52

Pharmaceutical Technology

MAY 24, 2023

Forge Biologics has joined the public-private collaboration, the Bespoke Gene Therapy Consortium (BGTC), to expedite the development and manufacture of new AAV [adeno-associated virus] gene therapies to treat patients with rare diseases. Shilling was appointed to represent the company on the steering committee of the BGTC.

Food and Drug Administration 96

Food and Drug Administration Manufacturing FDA Food 96

Pharmaceutical Technology

JUNE 2, 2023

Synaffix is focused on the commercialisation of its clinical-stage technology platform to develop ADCs that offer a range of potential targeted treatments for cancer. Synaffix ADC technology platform includes toxSYN, HydraSpace, and GlycoConnect technologies which can improve the tolerability and efficacy of ADCs.

Manufacturing 52

Manufacturing Leads Medical Marketing 52

European Pharmaceutical Review

FEBRUARY 6, 2023

The compound is in development for immunology and inflammation indications. Promisingly, EXS4318 was identified within 11 months after initiating design of the platform. EXS4318 (‘4318), a potentially first-in-class, potent and selective PKC theta inhibitor has entered first-in-human Phase I trials in the US.

Sales 92

Sales Pharmaceutical 92

Pharmaceutical Technology

MAY 17, 2023

AGC Biologics has introduced the BravoAAV and ProntoLVV viral vector platforms that offer quick clinical and commercial production and release of good manufacturing practices (GMP). Both platforms use the company’s development, manufacturing and analytical capabilities in lentiviral vector (LVV) and adeno-associated viral vector (AAV).

Manufacturing 52

Manufacturing Networking Patients Leads 52

Pharmaceutical Technology

APRIL 12, 2023

Clinical-stage biotechnology firm LyGenesis has formed a joint research collaboration with Imagine Pharma to develop new cell therapies for type 1 diabetes (T1D). In June 2022, the company discovered T1D AIPCs, a critical component to treat T1D through autologous cell transplantation.

Pharma 98

Pharma Leads Patients Pharmaceutical 98

Pharmaceutical Technology

APRIL 20, 2023

Targovax has unveiled plans to rebrand as Circio , reflecting its strategic shift to focus on expediting the development of its innovative circular RNA (circRNA) platform. Circio aims to develop new circRNA medicines initially for cancer, then plans to expand rapidly into vaccines and gene therapy.

Engineering 96

Engineering Leads Medicine Pharmaceutical 96

pharmaphorum

OCTOBER 12, 2022

The new disease management platform will allow for better patient treatment adherence tracking, according to the company, which says it will create an “end-to-end” digital health programme that will support patients “from the prevention and diagnosis phases, to disease management, and more, across multiple therapeutic areas.”

Management 82

Management Pharma Healthcare Provider Healthcare 82

Legacy MEDSearch

AUGUST 15, 2022

a global therapy-enabling platform company providing navigation and delivery to the brain, announced it has received 510(k) clearance for its ClearPoint Maestro Brain00 Model. This is a crucial first step in our path to make the Maestro Brain Model the ‘engine’ in our navigation system supporting multiple new applications in the future.

FDA 98

FDA Recruitment Safety Patients 98

Pharmaceutical Technology

FEBRUARY 23, 2023

This collaboration will enable us to utilise our cutting-edge GMP plasmid manufacturing platform technology to support the development of mRNA-based Covid-19 vaccine and its therapeutic candidates.” With its technical strength and customer-centric approach, GenScript ProBio will help to accelerate the development of RVAC’s pipeline.”

Manufacturing 115

Manufacturing Medicine Consulting Pharmaceutical 115

Pharmaceutical Technology

APRIL 11, 2023

Biotechnology company CTRL Therapeutics has announced $10m in seed financing to boost the development of a next-generation cell therapy platform to treat solid tumours. The platform is being developed using inputs from tumour-infiltrating lymphocyte (TIL) therapies.

Engineering 52

Engineering Patients Leads 52

Pharmaceutical Technology

APRIL 14, 2023

The company and the researchers, with Professor Krishanu Saha as principal investigator (PI) and Dr Christian Capitini as co-PI, will develop a GD2 CAR T-cell therapeutic candidate to treat neuroblastoma, a cancer type that generally affects young children.

Engineering 105

Engineering Patients Leads Pharmaceutical 105

Pharmaceutical Technology

JANUARY 5, 2023

Capsida Biotherapeutics and Eli Lilly and Company ’s wholly owned subsidiary Prevail Therapeutics have announced a partnership for the development of non-invasive gene therapies for central nervous system (CNS) diseases. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva.

Engineering 95

Engineering Leads Pharmaceutical Marketing 95

Pharmaceutical Technology

APRIL 27, 2023

Orbital will use the new funding to increase the application of RNA-based medicines for use in the fields of new vaccines, immunomodulation and protein replacement. The company is currently developing an RNA platform capable of combining well-known and upcoming RNA technologies and delivery systems.

Medicine 52

Medicine Leads Patients Pharmaceutical 52

Pharmaceutical Technology

APRIL 11, 2023

We could see using the platform at any major medical centre, so you could reach a significant number of patients. The platform we use to capture cells is very fast, which brings the cost down, and medical centres are comfortable handling blood.”

Food and Drug Administration 97

Food and Drug Administration Engineering Food Medical 97

Infuse Medical

APRIL 15, 2024

Software learning has evolved significantly over the years, transitioning from static textbooks and classroom lectures to dynamic online platforms and interactive tutorials. The rapid advancement of technology has reshaped the way individuals acquire software skills, with a growing emphasis on experiential learning and practical application.

Training 52

Training Education Competition Marketing 52

Pharmaceutical Technology

MAY 26, 2023

The European Medicines Agency (EMA) has accepted two marketing authorisation applications (MAA) from Sandoz for the proposed biosimilar denosumab. The MAAs include all indications covered by the Xgeva (denosumab) and Prolia (denosumab) reference medicines to treat conditions such as osteoporosis in postmenopausal women.

Food and Drug Administration 52

Food and Drug Administration Marketing Medicine Food 52

Veeva

MARCH 28, 2022

The Veeva Vault Platform consists of multiple product suites across both the Veeva Development Cloud and Commercial Cloud. Each suite contains multiple unified applications with flexible configuration options to meet organizational needs. If you are a new customer, the applicable connection is part of the initial implementation.

Management 52

Management 52

Pharmaceutical Technology

MARCH 24, 2023

Moderna has entered a strategic partnership with Generation Bio for the development of non-viral genetic medicines. Moderna’s biological and technical expertise will be combined with core technologies of the non-viral genetic medicine platform from Generation Bio.

Medicine 52

Medicine Sales Patients 52

Pharmaceutical Technology

JANUARY 3, 2023

The second programme involves the development of a new bispecific antibody with potential applications in solid tumours using Alligator’s Ruby platform. The initiation of this second project is a testament to the strength of Alligator’s technology platform, including our bispecific RUBY format.”.

Sales 52

Sales Pharmaceutical 52

Pharmaceutical Technology

APRIL 24, 2023

The companies aim to improve GA patients’ outcomes by combining RetinAl’s Discovery platform and AI tools with the retinal diseases research of Boehringer Ingelheim. RetinAI stated that combining advanced digital technologies with AI could help expedite the development of new treatments, enabling earlier diagnosis of diseases.

Medical 52

Medical Patients Pharmaceutical 52

PM360

DECEMBER 14, 2023

The pharma company has joined the Coalition for Epidemic Preparedness Innovations (CEPI) in a partnership that aims to shorten vaccine development timelines down to 100 days. The two companies are teaming up to figure out how to accelerate Moderna’s existing mRNA platform in identifying a vaccine for future viruses.

Physicians 52

Physicians Pharma Medical Patients 52

Pharmaceutical Technology

MAY 12, 2023

Matinas said it developed this unique formulation to “handle the physical complexity and biological fragility of mRNA”. In April 2022, BioNTech paid an upfront access fee to use Matinas’ LNC delivery platform technology. At the time, BioNTech was excited to see what the LNC platform could do for the oral delivery of mRNA therapeutics.

Leads 52

Leads Pharmaceutical Patients 52

Medgadget

FEBRUARY 14, 2023

Monitoring these characteristics could help to personalize treatment for individuals and also provide data for drug development and inform government decisions on the best way to manage COVID-19 in the community.

Engineering 90

Engineering Government Patients Manufacturing 90

pharmaphorum

SEPTEMBER 16, 2022

Now, Verily has announced that early results from its “next generation immune mapping technology” Immune Profiler platform have already identified “more effective therapeutic options against G protein-coupled receptors (GPCR) in autoimmune and other immune-mediated diseases”. Human-first precision health.

Leads 122

Leads Patients Medicine FDA 122

Pharmaceutical Technology

JUNE 7, 2023

Clinical-stage biotechnology company Acepodia has raised $100m in a Series D financing round to advance the first-in-class cell therapies being developed using the antibody-cell conjugation (ACC) platform. The financing round, led by Digital Mobile Venture, has also seen participation from other existing investors.

Patients 59

Patients Leads Pharmaceutical 59